版權(quán)說(shuō)明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)
文檔簡(jiǎn)介
MULTIPLESCLEROSISMULTIPLESCLEROSISDEFINITIONOFMSItisdefinedclinicallybytheinvolvementofdifferentpartsoftheCNSatdifferenttimes-providedthatotherdisorderscausingmultifocalcentraldysfunctionhavebeenexcludedDEFINITIONOFMSItisdefinedEPIDEMIOLOGYInitialsymptomsgenerallycommencebeforetheageof55yearsoldwithapeakincidencebetweenages20and40.WomenareaffectednearlytwiceasoftenasmenEPIDEMIOLOGYInitialsymptomsgEPIDEMIOLOGYANDGENETICSIncidencerateinUnitedStates::30-60/100,000lessthan5/100,000inAsiaGeographicGradientsandincidenceratesEquator:lowLatitude40oNand40oSEPIDEMIOLOGYANDGENETICSIncidGENETICFACTORSINMSGeneticpredispositionissuggestedbytwinstudiesTwins:monozygotic30%dizygotic4%TheoccasionalfamilialincidenceandstrongassociationbetweenthediseaseandspecificHLAalleles(HLA-DRB*15:1,HLA-DB1*15:03)AllelsofIL2RAandIL7RAGENETICFACTORSINMSGeneticpPathologyDemyelinativelesionsarecommonlyincerebralhemisphere,opticnerve,spinalcord,brainstem,cerebellum.Periventricular–scatteredareasofdemyelinationfollowedbyareactivegliosis,theremaybeaxonaldamageaswellTheselesionoccurinthewhitematterofthebrainandcordandinoptic(II)nervePathologyDemyelinativelesionsPathophysiologyThecauseofMSisunknown,buttissuedamageandneurologicalsymptomsarethroughttobetriggeredbyanimmunemechanismdirectedagainstmyelinantigensViralinfectionorotherincitingfactorsmaypromotetheentryofTcellsandantibodiesintotheCNSbydisruptingtheblood–brainbarrierPathophysiologyThecauseofMSInitialorPresentingSymptoms&Signs:Commoninitialcomplaintsarefocalweakness,numbness,tingling,orunsteadinessinalimb,LhermittesignSuddenlossorblurringofvisioninoneeye(opticneuritis)Diplopia,internuclearophthalmoplegia,nystagmusDisequilibriumBladder-functiondisturbance(urinaryurgencyorhesitancy)suchsymptomsareoftentransient,disappearing
afterafewdaysorweekswithresidualdeficitCLINCALFEATURESOFMSInitialorPresentingSymptoms神經(jīng)病學(xué)英文課件:07MULTIPLESCLEROSISOtherpatientspresentwithanacuteorgraduallyprogressivespasticparapresisandsensorydeficitSubsequentCourse:IntervalofmonthsoryearsaftertheinitialepisodebeforefurtherneurologicsymptomsappearNewsymptomsmaythendevelop,ororiginalonesmayrecurandprogress.Relapsesmaybetriggeredbyinfectionand,inwomen,aremorelikelyinthe3monthsorsofollowingchildbirthCLINCALFEATURESOFMSOtherpatientspresent神經(jīng)病學(xué)英文課件:07MULTIPLESCLEROSISAriseinbodytemperaturecancausetransientdeteriorationinpatientwithafixedandstabledeficitWithtime-andafteranumberofrelapsesandusuallyincompleteremissions-thepatientmaybecomeincreasingdisabledbyweakness,stiffness,sensorydisturbances,unsteadinessofthelimbs,impairedvision,andurinaryincontinenceBasedonitscourse,thediseaseisdividedinto4majortypesCLINCALFEATURESOFMSAriseinbodytemperaturecanCLINICALSUBTYPESOFMS
Relapsingremitting(RR)ProgressiondoesnotoccurbetweenattacksPrimaryprogressive(PP)ThereisgradualprogressionofdisabilityfromclinicalonsetSecondaryprogressive(SP)AprogressivecourseafteraninitialRRpatternProgressiverelapsing(PR)CLINICALSUBTYPESOFMSRelapsMRIFINDINGSSUPPORTIVEOFMSDIAGNOSIS1GD-DTPAcontrastenhancelesionOR9noncontrastenhancehighsignallesionsonMRT2sequenceAtleast1periventricularlesionAtleast1infratentorial(Brainstemorcerebellar)lesionAtleast1juxtacorticallesionOvoidlesionsperpendicularOpenringonGadT1-weightedSpinalMRItor/ocongenitaloracquiredsurgicaltreatablelesionMRIFINDINGSSUPPORTIVEOFMS神經(jīng)病學(xué)英文課件:07MULTIPLESCLEROSIS神經(jīng)病學(xué)英文課件:07MULTIPLESCLEROSISCEREBROSPINALFLUIDINMSMildlymphocytosisNormalglucoseNormalormodestincreaseinproteinAbsentredbloodcellsIncreasedIgGIndex/SynthesisOligoclonalbands~90%CEREBROSPINALFLUIDINMSMild神經(jīng)病學(xué)英文課件:07MULTIPLESCLEROSISLABTESTSMonocularvisualstimulationwithacheckerboardpattern(visualevokedpotentials,VEPs)Monauralstimulationwithrepetitiveclicks(brainstemauditoryevokedpotentials,BAEPs)Electricalstimulationofaperiphralnerve(somatosensoryevokedpotentials,SEPs)oneormoreabnorminMSLABTESTSMonocularvisualstim神經(jīng)病學(xué)英文課件:07MULTIPLESCLEROSISSCHUMACHERCRITERIAFORMSOnsetatappropriateageCNSwhitematterdisease
DisseminatedintimeandspaceObjectiveabnormalitiesAttackslastingover24hoursonemonthapartGradualorstepwiseprogressionNoalternativediagnosisSCHUMACHERCRITERIAFORMSOnseDiagnosisCriteriaforMS
Poser(1983)
ClinicaldefiniteMS,CDMSLaboratory-supporteddefiniteMS,LSDMSClinicalprobableMS,CPMSLaboratory-supportedprobableMS,LSPMSDiagnosisCriteriaforMS
Pose2005Rev.McDonaldCriteria2005Rev.McDonaldCriteriaEDSSforMS
theExpandedDisabilityStatusScale
neurologicaltestingoffunctionalsystem1.Pyramidalfunction(abilitytowalk)2.Cerebellarfunction(coordination)3.BrainStem(speech&swallowing)4.Sensory(touch&pain)EDSSforMS
theExpandedDisabEDSSforMS
neurologicaltestingoffunctionalsystem5.Bowel&bladder6.Visual7.Mental8.OtherEDSSforMS
neurologicaltestiEDSSforMS
theExpandedDisabilityStatusScaleFrom0.0normalneurologicalexamto10.0-deathe.g.6.0intermittentorunilateralconstantassistance(cane,crutchorbrace)requiredtowalk100meterswithorwithoutrestinge.g.8.0essentiallyrestrictedtobed,chairorwheelchair,butmaybeoutofbedmuchofday;retainsselfcarefunctions,generallyeffectiveuseofarmsEDSSforMS
theExpandedDisabDIFFERENTIALDIAGNOSISOFMS-NeuromyelitisOptica(NMO)Neuromyelitisoptica:isarelapsingdisorder(formerlyknownasDevicdiseaseandonceconsideredavariantofMS)isassociatedwuthaspecificantibodymarker,NMO-IgG,thattargetsthewaterchannelaquaporin-4.ThefullyestablisheddisorderischararcterizedbyopticneuritisandacutemyelitisandassocitedwithMRIchangesthatextendoveratleast3segmentsofthespinalDIFFERENTIALDIAGNOSISOFMS-NDIFFERENTIALDIAGNOSISOFMS-NeuromyelitisOptica(NMO)Usuallynobrainstem,cerebellar,orcerebraldemyelinativelesionandnormalityonMRIofwhitematter,absenceofOBbandandIgGinCSF,moreinAsiacountriesAcuteattacktreatedwithMPpusal,IVIG,PEwithlongtermimmnosuppressivetheraphyDIFFERENTIALDIAGNOSISOFMS-NDIFFERENTIALOFMS-AcuteDisseminatedEncephalomyelitis(ADEM)Occursasasingleepisodeofneurologicalsymptomssandsignsdevelopedinfewdaysassociatedwithnonspecificviralinfectionorafterimmunization.CSFisnlorProteinincreased,GlucosenlMRIishelpfulinwhitematterlesionevenwithgraymatter.DIFFERENTIALOFMS-AcuteDisseIMMUNOPROPHYLACTIC
AGENTSFORRRMSINTERFERONINTERFERONbeta-1b(Betaseron)Subcutaneous,everyotherdayrecombinantprotein–Ecol,250μgINTERFERONbeta-1a(AVONEX)IM,weekly,recombinantprotein,30μgINTERFERONbeta1-a(REBIF)SQ3X/WEEK22OR44μgMayuseformorethan2yearsGlatirameracetate(Copaxone)Syntheticpolypeptide,subcut20mgdailyIMMUNOPROPHYLACTIC
AGENTSFORIMMUNOPROPHYLACTIC
AGENTSFORRRMSNatalizumab,analpha4integrinantibody,reducestherelapsingrate,butinrareunstancesisassociatedwithprogressivemultifocalleukoencephalopathyMethyl-predinisolone(1gdaily)3-5days,followedbyanoralprednisonetaper(80mg/dforaweek,withrapidreductionovertheensuing1-2weeks)Intravenousimmunoglobulin(IVIG)0.4g/kgfor5daysORPlasmapheresis(PE)IMMUNOPROPHYLACTIC
AGENTSFORTREATMENTOFFEREDFORSPANDPPMSCyclophosphamideAzathiopprine/methotrexateCladribine/cyclosporineMitoxantroneSteroidpulsewithhigh-doseIVMP1.0gonceamonthIFN-beta-1beffectiveTREATMENTOFFEREDFORSPANDTREATMENTOFACUTEEXACERBATIONSOFMSGlucocorticosteroidsHigh-dosei.v.methylprednisolone0.5to1.0g/dayvariablecombinationsPlasmaExchange
TREATMENTOFACUTEEXACERBATIOPROGNOSISAtleastpartialrecoveryfromanacuteepisodecanbeanticipated,butitisimpossibletopredictwhenthenextrelapsewilloccure.Morefavorableprognosis:female,onsetbefore40,andpresentationwithvisualorsomatosensory,ratherthanpyramidalorcellellardysfunction.About50%ofallpatientsareonlymildlyormoderatelydisabled10yearsaftertheonsetofsymptomsPROGNOSISAtleastpartialrecTHANKS!THANKS!MULTIPLESCLEROSISMULTIPLESCLEROSISDEFINITIONOFMSItisdefinedclinicallybytheinvolvementofdifferentpartsoftheCNSatdifferenttimes-providedthatotherdisorderscausingmultifocalcentraldysfunctionhavebeenexcludedDEFINITIONOFMSItisdefinedEPIDEMIOLOGYInitialsymptomsgenerallycommencebeforetheageof55yearsoldwithapeakincidencebetweenages20and40.WomenareaffectednearlytwiceasoftenasmenEPIDEMIOLOGYInitialsymptomsgEPIDEMIOLOGYANDGENETICSIncidencerateinUnitedStates::30-60/100,000lessthan5/100,000inAsiaGeographicGradientsandincidenceratesEquator:lowLatitude40oNand40oSEPIDEMIOLOGYANDGENETICSIncidGENETICFACTORSINMSGeneticpredispositionissuggestedbytwinstudiesTwins:monozygotic30%dizygotic4%TheoccasionalfamilialincidenceandstrongassociationbetweenthediseaseandspecificHLAalleles(HLA-DRB*15:1,HLA-DB1*15:03)AllelsofIL2RAandIL7RAGENETICFACTORSINMSGeneticpPathologyDemyelinativelesionsarecommonlyincerebralhemisphere,opticnerve,spinalcord,brainstem,cerebellum.Periventricular–scatteredareasofdemyelinationfollowedbyareactivegliosis,theremaybeaxonaldamageaswellTheselesionoccurinthewhitematterofthebrainandcordandinoptic(II)nervePathologyDemyelinativelesionsPathophysiologyThecauseofMSisunknown,buttissuedamageandneurologicalsymptomsarethroughttobetriggeredbyanimmunemechanismdirectedagainstmyelinantigensViralinfectionorotherincitingfactorsmaypromotetheentryofTcellsandantibodiesintotheCNSbydisruptingtheblood–brainbarrierPathophysiologyThecauseofMSInitialorPresentingSymptoms&Signs:Commoninitialcomplaintsarefocalweakness,numbness,tingling,orunsteadinessinalimb,LhermittesignSuddenlossorblurringofvisioninoneeye(opticneuritis)Diplopia,internuclearophthalmoplegia,nystagmusDisequilibriumBladder-functiondisturbance(urinaryurgencyorhesitancy)suchsymptomsareoftentransient,disappearing
afterafewdaysorweekswithresidualdeficitCLINCALFEATURESOFMSInitialorPresentingSymptoms神經(jīng)病學(xué)英文課件:07MULTIPLESCLEROSISOtherpatientspresentwithanacuteorgraduallyprogressivespasticparapresisandsensorydeficitSubsequentCourse:IntervalofmonthsoryearsaftertheinitialepisodebeforefurtherneurologicsymptomsappearNewsymptomsmaythendevelop,ororiginalonesmayrecurandprogress.Relapsesmaybetriggeredbyinfectionand,inwomen,aremorelikelyinthe3monthsorsofollowingchildbirthCLINCALFEATURESOFMSOtherpatientspresent神經(jīng)病學(xué)英文課件:07MULTIPLESCLEROSISAriseinbodytemperaturecancausetransientdeteriorationinpatientwithafixedandstabledeficitWithtime-andafteranumberofrelapsesandusuallyincompleteremissions-thepatientmaybecomeincreasingdisabledbyweakness,stiffness,sensorydisturbances,unsteadinessofthelimbs,impairedvision,andurinaryincontinenceBasedonitscourse,thediseaseisdividedinto4majortypesCLINCALFEATURESOFMSAriseinbodytemperaturecanCLINICALSUBTYPESOFMS
Relapsingremitting(RR)ProgressiondoesnotoccurbetweenattacksPrimaryprogressive(PP)ThereisgradualprogressionofdisabilityfromclinicalonsetSecondaryprogressive(SP)AprogressivecourseafteraninitialRRpatternProgressiverelapsing(PR)CLINICALSUBTYPESOFMSRelapsMRIFINDINGSSUPPORTIVEOFMSDIAGNOSIS1GD-DTPAcontrastenhancelesionOR9noncontrastenhancehighsignallesionsonMRT2sequenceAtleast1periventricularlesionAtleast1infratentorial(Brainstemorcerebellar)lesionAtleast1juxtacorticallesionOvoidlesionsperpendicularOpenringonGadT1-weightedSpinalMRItor/ocongenitaloracquiredsurgicaltreatablelesionMRIFINDINGSSUPPORTIVEOFMS神經(jīng)病學(xué)英文課件:07MULTIPLESCLEROSIS神經(jīng)病學(xué)英文課件:07MULTIPLESCLEROSISCEREBROSPINALFLUIDINMSMildlymphocytosisNormalglucoseNormalormodestincreaseinproteinAbsentredbloodcellsIncreasedIgGIndex/SynthesisOligoclonalbands~90%CEREBROSPINALFLUIDINMSMild神經(jīng)病學(xué)英文課件:07MULTIPLESCLEROSISLABTESTSMonocularvisualstimulationwithacheckerboardpattern(visualevokedpotentials,VEPs)Monauralstimulationwithrepetitiveclicks(brainstemauditoryevokedpotentials,BAEPs)Electricalstimulationofaperiphralnerve(somatosensoryevokedpotentials,SEPs)oneormoreabnorminMSLABTESTSMonocularvisualstim神經(jīng)病學(xué)英文課件:07MULTIPLESCLEROSISSCHUMACHERCRITERIAFORMSOnsetatappropriateageCNSwhitematterdisease
DisseminatedintimeandspaceObjectiveabnormalitiesAttackslastingover24hoursonemonthapartGradualorstepwiseprogressionNoalternativediagnosisSCHUMACHERCRITERIAFORMSOnseDiagnosisCriteriaforMS
Poser(1983)
ClinicaldefiniteMS,CDMSLaboratory-supporteddefiniteMS,LSDMSClinicalprobableMS,CPMSLaboratory-supportedprobableMS,LSPMSDiagnosisCriteriaforMS
Pose2005Rev.McDonaldCriteria2005Rev.McDonaldCriteriaEDSSforMS
theExpandedDisabilityStatusScale
neurologicaltestingoffunctionalsystem1.Pyramidalfunction(abilitytowalk)2.Cerebellarfunction(coordination)3.BrainStem(speech&swallowing)4.Sensory(touch&pain)EDSSforMS
theExpandedDisabEDSSforMS
neurologicaltestingoffunctionalsystem5.Bowel&bladder6.Visual7.Mental8.OtherEDSSforMS
neurologicaltestiEDSSforMS
theExpandedDisabilityStatusScaleFrom0.0normalneurologicalexamto10.0-deathe.g.6.0intermittentorunilateralconstantassistance(cane,crutchorbrace)requiredtowalk100meterswithorwithoutrestinge.g.8.0essentiallyrestrictedtobed,chairorwheelchair,butmaybeoutofbedmuchofday;retainsselfcarefunctions,generallyeffectiveuseofarmsEDSSforMS
theExpandedDisabDIFFERENTIALDIAGNOSISOFMS-NeuromyelitisOptica(NMO)Neuromyelitisoptica:isarelapsingdisorder(formerlyknownasDevicdiseaseandonceconsideredavariantofMS)isassociatedwuthaspecificantibodymarker,NMO-IgG,thattargetsthewaterchannelaquaporin-4.ThefullyestablisheddisorderischararcterizedbyopticneuritisandacutemyelitisandassocitedwithMRIchangesthatextendoveratleast3segmentsofthespinalDIFFERENTIALDIAGNOSISOFMS-NDIFFERENTIALDIAGNOSISOFMS-NeuromyelitisOptica(NMO)Usuallynobrainstem,cerebellar,orcerebraldemyelinativelesionandnormalityonMRIofwhitematter,absenceofOBbandandIgGinCSF,moreinAsiacountriesAcuteattacktreatedwithMPpusal,IVIG,PEwithlongtermimmnosuppressivetheraphyDIFFERENTIALDIAGNOSISOFMS-NDIFFERENTIALOFMS-AcuteDisseminatedEncephalomyelitis(ADEM)Occursasasingleepisodeofneurologicalsymptomssandsignsdevelopedinfewdaysassociatedwithnonspecificviralinfectionorafterimmunization.CSFisnlorProteinincreased,GlucosenlMRIishelpfulinwhitematterlesionevenwithgraymatter.DIFFERENTIALOF
溫馨提示
- 1. 本站所有資源如無(wú)特殊說(shuō)明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
- 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
- 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁(yè)內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒(méi)有圖紙預(yù)覽就沒(méi)有圖紙。
- 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
- 5. 人人文庫(kù)網(wǎng)僅提供信息存儲(chǔ)空間,僅對(duì)用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
- 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
- 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。
最新文檔
- 2025具備履行合同所必需的設(shè)備和專業(yè)技術(shù)能力的
- 企業(yè)機(jī)房建設(shè)與改造項(xiàng)目
- 企業(yè)保潔外包合同案例
- 棒球訓(xùn)練館租賃合同范本
- 2025論壇版塊承包租賃合同范本
- 2025年度香菇食品出口退稅代理服務(wù)合同2篇
- 合同條款解讀手冊(cè)
- 信息技術(shù)公司聘用合同樣本
- 橄欖球俱樂(lè)部暖氣安裝施工合同
- 2024拆遷回遷住宅小區(qū)購(gòu)房合同
- 2025年河南鶴壁市政務(wù)服務(wù)和大數(shù)據(jù)管理局招聘12345市長(zhǎng)熱線人員10人高頻重點(diǎn)提升(共500題)附帶答案詳解
- 建設(shè)項(xiàng)目安全設(shè)施施工監(jiān)理情況報(bào)告
- 春節(jié)期間安全施工措施
- 2025年大唐集團(tuán)招聘筆試參考題庫(kù)含答案解析
- 路面彎沉溫度修正系數(shù)
- 2022年湖北省武漢市中考數(shù)學(xué)試卷含解析
- TLFSA 003-2020 危害分析與關(guān)鍵控制點(diǎn)(HACCP)體系調(diào)味面制品生產(chǎn)企業(yè)要求
- LY/T 2244.3-2014自然保護(hù)區(qū)保護(hù)成效評(píng)估技術(shù)導(dǎo)則第3部分:景觀保護(hù)
- 紀(jì)律教育月批評(píng)與自我批評(píng)五篇
- GB/T 26480-2011閥門的檢驗(yàn)和試驗(yàn)
- GB/T 13342-2007船用往復(fù)式液壓缸通用技術(shù)條件
評(píng)論
0/150
提交評(píng)論